Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Malaria Journal|October 3, 2021
In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018Abel Nhama, Lídia Nhamússua, Eusébio Macete, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2025
Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020Aina Harimanana, Dina Ny Aina Liantsoa Randriamiarinjatovo, Tovonanahary Angelo Rakotomanga, et al.
Emerging Infectious Diseases|January 29, 2021
Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020Alexandra M Medley, Barbara J Marston, Mitsuru Toda, et al.
The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.
Malaria Journal|May 26, 2021
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016Youssouf Diarra, Oumar Koné, Lansana Sangaré, et al.
Malaria Journal|December 1, 2022
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in EthiopiaAshenafi Assefa, Hussein Mohammed, Anjoli Anand, et al.
Malaria Journal|December 25, 2021
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in UgandaChris Ebong, Asadu Sserwanga, Jane Frances Namuganga, et al.
Malaria Journal|June 12, 2025
Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatmentVeronika R Laird, Mateusz M Plucinski, Meera Venkatesan, et al.
The American Journal of Tropical Medicine and Hygiene|September 7, 2021
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial ResistanceLeah F Moriarty, Papy Mandoko Nkoli, Joris Losimba Likwela, et al.
The Lancet. Infectious Diseases|April 17, 2021
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy studyAline Uwimana, Noella Umulisa, Meera Venkatesan, et al.
Pageof 3